Guide For Authors

AIMS AND SCOPE

Asthma Allergy Immunology has been published three times a year in April, August and December as the official and periodical journal of the Turkish National Society of Allergy and Clinical Immunology since 2003. All articles published in the journal have been available online since 2003. A peer reviewed system is used in evaluation of the manuscripts submitted to Asthma Allergy Immunology. The official language of the journal is English.

The aim of the journal is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal.

The target reader population of the Asthma Allergy Immunology includes specialists and residents of allergy and clinical immunology, pulmonology, internal medicine, pediatrics, dermatology and otolaryngology as well as physicians working in other fields of medicine interested in allergy and immunological diseases.

Asthma Allergy Immunology is indexed in Turkish Medical Index of TUBITAK/ULAKBIM, EBSCOhost Research Databases, Index Copernicus, CINAHL, Turkey Citation Index and ISI Web of Science - Emerging Sources Citation Index.

Subscription Procedures

Asthma Allergy Immunology is distributed to members of the Turkish National Society of Allergy and Clinical Immunology free of charge. Content, abstract and full text of all the articles published since 2003 can be found at www.aid.org.tr. Annual subscription fee of the journal for nonmembers is: 60 TL for individuals, 75 TL for library and institutions. Single issue price is 30 TL. Subscription fee for the ones from other countries is 120 US$. Subscription orders should be sent to the General Secretary of the Turkish National Society of Allergy and Clinical Immunology accompanied by the bank receipt of the subscription fee. Subscription fee should be paid to the account of the Turkish National Society of Allergy and Clinical Immunology in Yapı Kredi Bank Hacettepe office account number 1920159-1. Turkish National Society of Allergy and Clinical Immunology should be contacted for commercial reprint orders.

Address:
Turkish National Society of Allergy and Clinical Immunology
Mustafa Kemal Mahallesi, 2124. Sokak Yasam Is Merkezi
No: 16/3-4 Sogutozu, 06520 Cankaya-Ankara
Phone: +90 312 219 66 31 Fax: +90 312 219 66 57
E-mail: [email protected]
Web: www.aid.org.tr

Permission Request

Manuscripts, pictures, figures, graphics and tables published in the Asthma Allergy Immunology can not be reproduced, archived in a system, used in advertisement materials, without the written permission of the Turkish National Society of Allergy and Clinical Immunology. Citations can be included in scientific articles with referral.

Instructions for Authors

Instructions for authors can be accessed from www.aid.org.tr and printed samples of the journal.

Scientific and Legal Responsibility of the Articles

Scientific and legal responsibility of the published articles belongs to the authors. Authors are responsible for the contents of the articles and accuracy of the references. Turkish National Society of Allergy and Clinical Immunology, the Editor, the Associated Editors or the publisher do not accept any responsibility for the published articles.

The journal is printed on acid-free paper.

 


INSTRUCTIONS TO THE AUTHORS

1. Asthma Allergy Immunology is the periodical journal of the Turkish National Society of Allergy and Clinical Immunology, which is published three times a year.

2. The aim of the journal; is to present advances in the field of allergic diseases and clinical immunology to the readers. In accordance with this goal, manuscripts in the format of original research, review, case report, articles about clinical and practical applications and editorials, short report and letters to the editor about allergic diseases and clinical immunology are published in the journal.

3. The official language of the journal is English.

4. All manuscripts submitted for publication should comply with “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” produced and updated by the International Committee of Medical Journals Editors (www.icmje.org).

5. Compliance with the Declaration of Helsinki Principles (http://www.wma.net/en/30publications/10policies/b3/index.html) is accepted as the policy of Asthma Allergy Immunology. Therefore, all manuscripts concerning human subjects must contain a statement in the “Materials and Methods” section, indicating that the study was approved by the Institutional Review Board. All study subjects should be informed and written consent should be obtained and this should be declared in the “Materials and Methods” section. All manuscripts dealing with animal subjects must contain a statement indicating that the study was performed according to “The Guide for the Care and Use of Laboratory Animals” (www.nap.edu/catalog/5140.html) with the approval of the Institutional Review Board, in the “Materials and Methods” section. The Editor may ask for a copy of the approval document.

6. The editor has the right to format or reject the manuscripts which do not follow the rules or send them back to the author for correction. Authors who wish to withdraw their manuscripts need to state this to the editor in written form.

7. Submitted papers are reviewed by the, the editor, the associated editors, and at least two reviewers. The editor and associated editors may decide to send the manuscript to a third reviewer. The editors are the complete authority regarding reviewer selection. The reviewers may be selected from the advisory board or independent national or international reviewers may be selected when required for the topic of the manuscript.

8. The dates of received and accepted of the manuscript are stated in the beginning of the manuscript when published in the journal.

9. The manuscripts should be submitted via online manuscript evaluation system (www.aai.org.tr). 10. The manuscript text should be written in Times New Roman font, 10 point-type, double-spaced with 2 cm margins on the left and right sides. The article should be prepared with IBM compatible computer programs (Microsoft Windows, Word 98). The pages should be numbered starting with the title page. Page numbers should appear at the bottom right corner of every page. The main text file should not contain any information regarding author names and affiliations.

11. A cover letter (author agreement form), signed by the authors in the same order of authors as stated in the article, declaring that the manuscript has not been published or is not currently submitted to another journal and that the manuscript is approved by all the authors should be e-mailed to [email protected] after being scanned or should be faxed to +90 0312 219 66 57 simultaneous with the online upload of the manuscript. The signed cover letter should include scientific contributions and responsibilities of each author, and whether there is a conflict of interest regarding manuscript.

This form is available on www.aai.org.tr. Original signed document shall be mailed to “Gül Karakaya, MD, Professor, Asthma Allergy Immunol Editor in Chief, Hacettepe University Faculty of Medicine, Department of Chest Diseases, Division of Adult Allergic Diseases, Ankara, Turkey” via post or cargo.

12. All the entities that provide contribution to the technical content, data collection and analysis, writing, revision etc. of the manuscript and yet do not meet the criteria to be an author should be mentioned in the acknowledgement part. If the contribution of the sponsor is only in the form of financial support, this should be stated in the “Acknowledgement” section. If the sponsor has participated in the methods, statistical analysis or manuscript preparation, this contribution should also be stated in the “Materials and Methods” section. If there is no conflict of interest it should also be stated.

13. The manuscript which has been presented previously as an abstract in any congress or symposium may be mentioned on condition with the statement of the date and the place of the meeting.

14. Abbreviations should be internationally accepted and should be defined accordingly in the text in parenthesis when first mentioned and used in the text. The abbreviated form should be used all throughout the article. “How To Write and Publish Scientific Articles” (http://journals.tubitak.gov.tr/kitap/maknasyaz/) can be referred for international abbreviations.

15. Title page of the manuscript should include title of the article, running title not exceeding 40 characters including spaces as well as the full names, surnames and academic degrees of the authors. The department, division and institution of the authors should be indicated. Title page should also include address, e-mail, phone and fax number of the corresponding author.

16. All manuscripts except “Letters to the Editor” should include abstract. Abbreviations should be avoided in abstract. References, figures, tables and citations should not be used.

17. There should be two to five key words complying with the Index Medicus medical Subject Headings (MeSH). Refer to www.nlm.nih.gov/mesh/MBrowser.html for key words.

18. RESEARCH ARTICLES Research Articles should include; title, structured abstract (limited to 300 words structured as Objective, Materials and Methods, Results and Conclusion), and key words. Other sections of the manuscript should include Introduction, Materials and Methods, Results, Discussion, Acknowledgement (if required) and References. All sections of the manuscripts should start on a new page. Research articles should not exceed 5000 words and 40 references.

19. REVIEWS Manuscripts in the form of “Reviews” are accepted when “invited” since 2009. In case of wishing to write a review about a current topic without being “invited”, the editor should be contacted before the manuscript is submitted. Review Articles should include; title, abstract, and key words. The abstract should be prepared as one paragraph and limited to 300 words. Structured abstract is not required. Number of references should be limited to 40 if possible.

20. CASE REPORTS Case reports should include title, abstract, key words, introduction, case presentation, discussion and references. Introduction and discussion sections of the case reports should be short and concise and the abstract should be prepared as one paragraph. Structured abstract is not required. Case reports should not exceed 1500 words and the number of references should not exceed 20.

21. SHORT REPORTS Short reports should include research results in the related field in a short and concise form. Short reports should be limited to 1500 words. Short reports should include title, abstract in one paragraph and key words. Number of tables should be limited to 2 and that of the figure/graphic/picture should be limited to 1. Structured abstract is not required. Number of references should be limited to 10.

22. LETTERS TO THE EDITORS Letters to the Editor should be short and concise limited to 1000 words and 10 references, since they are prepared to criticize or contribute to the articles previously published in the journal.

23. TABLES AND FIGURES Tables, figures, graphics and pictures should be numbered with Arabic numbers in order of reference in the text. Localization of tables, figures, graphics and pictures should be indicated.

Each table should be prepared with double spacing on a separate page. Tables should have a brief title. Authors should place explanatory matter in footnotes, not in the heading. Explanations should be made for all nonstandard abbreviations in footnotes. The following symbols should be used for abbreviations in sequence: *,†,‡,§,||,¶,**,††,‡‡. Each table should be cited in text.

Figures should be either professionally drawn or photographed, and these items should be submitted as photographic-quality digital images. Figures should be submitted in a format that will produce high-quality image (for example, JPEG or GIF). Authors should control the images of such files on a computer screen before submitting them to be sure they meet their own quality standards.

X-ray films, scans and other diagnostic images, as well as pictures of pathology specimens should be submitted as sharp, glossy, black-and-white or color photographic images. Letters, numbers, and symbols on figures should be clear and consistent throughout, and large enough to remain legible when the figure is reduced for publication. Figures should be made as self-explanatory as possible. For recognizable photographs of patients, signed releases of the patient or of his/her legal representative should be submitted; otherwise, patient names or eyes must be blocked out to prevent identification.

Legends for figures, graphics and pictures should be typed starting on a separate page, double spaced, indicating the corresponding illustrations with numbers. When symbols, arrows, numbers or letters are used to identify parts of illustrations, should be defined clearly under the illustration.

If quoted parts, tables, figures, graphics, pictures etc exist in the manuscript, the authors should obtain written permission from the author and copyright holder and indicate this.

24. REFERENCES Data and manuscript not published yet should not be included among the references. These should be stated in the main text as “author(s), unpublished data, year”.

Reference numbers should be indicated at the end of the sentences in the text as superscripts and references should be numbered consecutively in the order they are mentioned in the text. Journal names should be abbreviated as listed in “Index Medicus” or in “ULAKBIM/Turkish Medical Index”. References should be typed in consistence with the following examples. National references should be used as much as possible.

If the reference is a journal;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “et al.”).Title of the article, title of the manuscript abbreviated according to Index Medicus (http://www.ncbi.nlm.nih.gov/sites/entrez/query. fcgi?db=nlmcatalog). Year;Volume:First and last page number.

Example: Benson M, Reinholdt J, Cardell LO. Allergen-reactive antibodies are found in nasal fluids from patients with birch poleninduced intermittent allergic rhinitis, but not in healthy controls. Allergy 2003;58:386-93.

If the reference is a journal supplement;

Author(s)’ surname and initial(s) of the first name. Title of the article. Title of the manuscript abbreviated according to Index Medicus (http://www.ncbi.nlm.nih.gov/sites/entrez/ query. fcgi?db=nlmcatalog). Year;Volume (Suppl. Supplement number):First and last page number.

Example: Queen F. Risk assessment of nickel carcinogenicity and occupational lung cancer. Envirol Health Perspect 1994;102 (Suppl. 1):S2755-S2782.

If the reference is a book;

Author(s)’ surname and initial(s) of the first name. Title of the book. Edition number. City of publication; Publisher, Year of Publication.

Example: Ringsven MK, Bond N. Gerontology and leadership skills for nurses. 2nd ed. Albany, NY: Delmar, 1996.

If the reference is a book chapter;

Surname and initial(s) of the first name of the author(s) of the chapter. Title of the chapter. In: Surname and initial(s) of the first name(s) of the editor(s) (ed) or (eds). Title of the book. Edition number. City of publication: Publisher, Year of publication: First and last page numbers of the chapter.

Example: Phillips SJ, Whistant JP. Hypertension and stroke. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management. 2 nd ed. New York: Raven P, 1995:466-78.

If the reference is an article presented in a meeting;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “et al.”).Title of the article, If applicable In:Surname and initial(s) of the first name(s) of the editor(s) (ed) or (eds). Title of the book. Title of the meeting; Date; City of the meeting; Country. Publisher; Year. Page numbers.

Example: Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O (eds). MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. North-Holland; 1992. p. 1561-5.

If the reference is an online journal;

Author(s)’ surname and initial(s) of the first name (all authors if the number of authors are 6 or less, first 6 authors if the number of authors of an article is more than 6 followed by “et al.”).Title of the article, title of the manuscript abbreviated according to Index Medicus Year; Volume (Number). Available from:URL address. Accessed date:day.month.year.

Example: Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis 1995;1(1). Available from: URL:http://www/cdc/gov/ncidoc/EID/eid.htm. Accessed date:25.12.1999.

If the reference is a website;

Name of the web site. Access date. Available from: address of the web site.

World Health Organization (WHO). Access date: 9 July 2008. Available from: http://www.who.int

If the reference is a thesis;

Author’s surname and initial of the first name. Title of the thesis (thesis). City; Name of the university (if it is a university); Year.

Example: Erkan ML. Investigation of clinical and laboratory features of asthma patients with aspirin sensitivity (Thesis). Ankara: Hacettepe Üniversity; 1989.

25. Scientific and legal responsibility of the published articles belong to the authors. Authors are responsible for the ideas and comments in the manuscript as well as the accuracy of the references. Turkish National Society of Allergy and Clinical Immunology, the Editor, the Associated Editors or the publisher do not accept any responsibility for the published articles. The copyright of the articles accepted for publication belong to the Turkish National Society of Allergy and Clinical Immunology. “Copyright Transfer Form” that will be sent to the e-mail of the corresponding author after acceptance of the manuscript for publication should be signed by all authors and sent via e-mail to or [email protected] and faxed to +90 0312 219 66 57.

This form is available on www.aai.org.tr. Original signed document shall be mailed to “Gül Karakaya, MD, Professor, Asthma Allergy Immunol Editor in Chief, Hacettepe University School of Medicine, Department of Chest Diseases, Division of Immunology and Allergic Diseases, Ankara, Turkey” via post or cargo.

26. There is no royalty payment to the authors.

27. Citation

Asthma Allergy Immunol

28. Publication Rights

Publication rights of Instructions to Authors of Asthma Allergy Immunology belong to the Bilimsel Tip Yayinevi and the Turkish National Society of Allergy and Clinical Immunology and all rights are reserved.

29. Manuscripts, figures and tables published in Asthma Allergy Immunology may not be reproduced in part or completely, archived in a retrieval system or used for advertising purposes without a written permission from the Turkish National Society of Allergy and Clinical Immunology. Quotations may be used in scientific articles as long as they are referred. Related company is responsible for the content of the advertisements published in the journal. The Asthma Allergy Immunology is available online free of charge and contents of the journal can be accessed from the journal’s website at: www. aai.org.tr.

Contact
Gül Karakaya, MD, Professor (Editor)
Address: Hacettepe University School of Medicine,
Department of Chest Diseases,
Division of Immunology and Allergic Diseases,
Ankara, Turkey
Phone: +90 312 305 17 21
E-mail: [email protected]


Tüm hakları saklıdır. © 2016 AAI